Memphasys Ltd
ASX:MEM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Puma SE
XETRA:PUM
|
DE |
|
J
|
Jafron Biomedical Co Ltd
SZSE:300529
|
CN |
Memphasys Ltd
Accounts Payable
Memphasys Ltd
Accounts Payable Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Payable | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
M
|
Memphasys Ltd
ASX:MEM
|
Accounts Payable
AU$726.6k
|
CAGR 3-Years
29%
|
CAGR 5-Years
22%
|
CAGR 10-Years
-2%
|
|
|
Genetic Technologies Ltd
ASX:GTG
|
Accounts Payable
AU$2.6m
|
CAGR 3-Years
22%
|
CAGR 5-Years
29%
|
CAGR 10-Years
10%
|
|
|
Proteomics International Laboratories Ltd
ASX:PIQ
|
Accounts Payable
AU$471.9k
|
CAGR 3-Years
87%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
|
|
T
|
Trajan Group Holdings Ltd
ASX:TRJ
|
Accounts Payable
AU$11.1m
|
CAGR 3-Years
9%
|
CAGR 5-Years
40%
|
CAGR 10-Years
N/A
|
|
|
Cryosite Ltd
ASX:CTE
|
Accounts Payable
AU$1.7m
|
CAGR 3-Years
29%
|
CAGR 5-Years
17%
|
CAGR 10-Years
5%
|
|
|
E
|
EZZ Life Science Holdings Ltd
ASX:EZZ
|
Accounts Payable
AU$3.5m
|
CAGR 3-Years
13%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
Memphasys Ltd
Glance View
Memphasys Ltd. is a life sciences company. The company is headquartered in Homebush West, New South Wales. The company went IPO on 2007-05-14. The company develops medical devices, diagnostics and media with application to assists reproduction technologies in humans and animals. The Company’s lead product is Felix device. The Felix is an automated device for separating quality sperm from a semen sample for the use in human in vitro fertilization (IVF) procedures. The firm's membrane technology utilizes its separation technology along with its multiple devices and hydrogel membranes to fractionate biological molecules. The technology relies on the applied electric field and charged biological molecules. The sample and harvest chamber are formed by placing the separation membrane in between two restriction membranes with restricted pores.
See Also
What is Memphasys Ltd's Accounts Payable?
Accounts Payable
726.6k
AUD
Based on the financial report for Dec 31, 2025, Memphasys Ltd's Accounts Payable amounts to 726.6k AUD.
What is Memphasys Ltd's Accounts Payable growth rate?
Accounts Payable CAGR 10Y
-2%
Over the last year, the Accounts Payable growth was 96%. The average annual Accounts Payable growth rates for Memphasys Ltd have been 29% over the past three years , 22% over the past five years , and -2% over the past ten years .
